Chapter 1. Preimplantation Genetics Diagnosis (PGD) Market- – Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Preimplantation Genetics Diagnosis (PGD) Market- – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. Preimplantation Genetics Diagnosis (PGD) Market- – Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Preimplantation Genetics Diagnosis (PGD) Market- - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4    .Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5. Preimplantation Genetics Diagnosis (PGD) Market- - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Preimplantation Genetics Diagnosis (PGD) Market- By Test Type
6.1    Chromosomal Abnormalities
6.2    Aneuploidy
6.3    X-linked diseases
6.4    Single Gene Disorders
6.5    HLA Typing
6.6    Gender selection
6.7    Others
Chapter 7. Preimplantation Genetics Diagnosis (PGD) Market- – By Region
7.1    North America
7.2    Europe
7.3    Asia-Pacific
7.4    Rest of the World
Chapter 8. Preimplantation Genetics Diagnosis (PGD) Market- - Key Players
8.1    Company 1
8.2    Company 2
8.3    Company 3
8.4    Company 4
8.5    Company 5
8.6    Company 6
8.7    Company 7
8.8    Company 8
8.9    Company 9
8.10    Company 10